InsidersTradesSigma
Follow the Syncom Formulations (India) Limited share price and the full management transaction log of the company, a listed equity based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Syncom Formulations (India) Limited has recorded 2 public disclosures. Market capitalisation: €12.3bn. The latest transaction was filed on 16 June 2023 (Sale). Among the most active insiders: Shankarlal Bankda HUF. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Syncom Formulations (India) Limited is a company engaged in the manufacturing of pharmaceutical products. It operates in the healthcare and pharmaceutical sector in India.